FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:1128-1135 September 11, 2008 Number 11 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Editorial by Levi, M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

SUMMARY

Impaired renal phosphate reabsorption, as measured by dividing the tubular maximal reabsorption of phosphate by the glomerular filtration rate (TmP/GFR), increases the risks of nephrolithiasis and bone demineralization. Data from animal models suggest that sodium–hydrogen exchanger regulatory factor 1 (NHERF1) controls renal phosphate transport. We sequenced the NHERF1 gene in 158 patients, 94 of whom had either nephrolithiasis or bone demineralization. We identified three distinct mutations in seven patients with a low TmP/GFR value. No patients with normal TmP/GFR values had mutations. The mutants expressed in cultured renal cells increased the generation of cyclic AMP (cAMP) by parathyroid hormone (PTH) and inhibited phosphate transport. These NHERF1 mutations suggest a previously unrecognized cause of renal phosphate loss in humans.

Source Information

From INSERM Unité 845, Université Paris Descartes, Faculté de Médecine (Z.K., N.B., R.A., C.L., L.B., G.P., P.U.-T., G.F., D.P.); Hôpital Bichat–Claude Bernard (B. Gérard, C.S., B. Grandchamp), Hôpital Necker–Enfants Malades (P.U.-T., G.F., D.P.), and Hôpital Européen Georges Pompidou (G.F.), Assistance Publique–Hôpitaux de Paris; and INSERM Unité 773, Unité de Formation et de Recherche Médicale (C.S.), and Institut Fédératif de Recherche 02, INSERM (B. Grandchamp), Université Paris Diderot — all in Paris; and Clinique du Landy, Saint Ouen, France (P.U.-T.).

Drs. Friedlander and Prié contributed equally to this article.

Address reprint requests to Dr. Prié at Service d'Explorations Fonctionnelles, Hôpital Necker–Enfants Malades, 149 Rue de Sèvres, Paris 75015, France, or at prie{at}necker.fr.

Full Text of this Article

Related Letters:

NHERF1 Mutations and Responsiveness of Renal Parathyroid Hormone
Bergwitz C., Bastepe M., Rendina D., De Filippo G., Strazzullo P., Prié D., Friedlander G.
Extract | Full Text | PDF  
N Engl J Med 2008; 359:2615-2617, Dec 11, 2008. Correspondence

This article has been cited by other articles:

• Prie, D., Friedlander, G. (2009). Genetic Causes of Renal Lithiasis. IBMS BoneKEy 6: 357-367 [Abstract] [Full Text]  
• Breusegem, S. Y., Takahashi, H., Giral-Arnal, H., Wang, X., Jiang, T., Verlander, J. W., Wilson, P., Miyazaki-Anzai, S., Sutherland, E., Caldas, Y., Blaine, J. T., Segawa, H., Miyamoto, K.-i., Barry, N. P., Levi, M. (2009). Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiency. Am. J. Physiol. Renal Physiol. 297: F350-F361 [Abstract] [Full Text]  
• Alexander, R. T., Grinstein, S. (2009). Tethering, recycling and activation of the epithelial sodium-proton exchanger, NHE3. J. Exp. Biol. 212: 1630-1637 [Abstract] [Full Text]  
• Wang, B., Yang, Y., Abou-Samra, A. B., Friedman, P. A. (2009). NHERF1 Regulates Parathyroid Hormone Receptor Desensitization: Interference with {beta}-Arrestin Binding. Mol. Pharmacol. 75: 1189-1197 [Abstract] [Full Text]  
• Bergwitz, C., Bastepe, M., Rendina, D., De Filippo, G., Strazzullo, P., Prie, D., Friedlander, G. (2008). NHERF1 Mutations and Responsiveness of Renal Parathyroid Hormone. NEJM 359: 2615-2617 [Full Text]  
• Levi, M., Breusegem, S. (2008). Renal Phosphate-Transporter Regulatory Proteins and Nephrolithiasis. NEJM 359: 1171-1173 [Full Text]